Alto
Transforming biomolecular characterization with digital microfluidics and nanotechnology Alto, the world’s first digital SPR platform, is designed [by Nicoya] to help scientists succeed.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Drug discovery - Pharma
The better option for SPR in the market, lower price with better throughput and much smaller footprint!
Review Date: 7 Apr 2021 | Nicoya
Transforming biomolecular characterization with digital microfluidics and nanotechnology Alto, the world’s first digital SPR platform, is designed [by Nicoya] to help scientists succeed.
Alto can accelerate all stages of your research programs by providing you with a fully-automated analysis of key biomolecular interactions. By harnessing digital microfluidics’ superior liquid handling abilities and nanotechnology-based precision engineering, Alto provides you with high-quality, label-free kinetic analysis using only 2 µl sample volume. Nicoya’s SPR platforms are currently empowering over 600 scientists from global biotechnology, pharmaceutical and research organizations to push the limits of their research and bring novel healthcare solutions to market.
Industry-Leading Data Quality
- Minimize noise and dispersion; maximize sensitivity
- The fastest rise times at <0.1s
Sample Friendly
- Only 2μL required for full kinetics
- Analyze crude samples with ease
High-Throughput Powered by Automation and AI
- 16 channels, intelligent assay design/optimization, automated serial dilutions
- Fully compatible with plate & liquid-handling robots
User Friendly
- Free of high-maintenance fluidic components and obsolete software